brdta1zhi9newra_UserUpload.Net

<25

Lung cancer incidence
(Rate per 100,000, 2017)

25-30

30-35

35-40

40-45

>45 Spain

Scorecard results

Indicator Range Score Justification

Lung cancer is a strategic priority

1 Operational,

comprehensive, up-to-

date national cancer

control plan

0 – 5 2  The Ministry of Health, Social Services and Equality published a Cancer Strategy of the

Spanish National Health System in 2010.^6

 The National Cancer Strategy includes implementation within the monitoring and

evaluation section of the plan.

 No funds are officially allocated in the National Cancer Strategy. The strategy consists of

recommendations. Each region has a specific financing system.

 A specific lung cancer control plan has not been published by the government or health

ministry.

2 Comprehensive clinical

guidelines for lung

cancer

0 – 6 4  The Spanish Society of Medical Oncology published lung cancer guidelines in 2018.^7

 The guidelines cover diagnosis, treatment, supportive / palliative care and strongly

recommend early palliative care.

 The guidelines do not mention screening or shared decision-making.

Lung cancer is a public health issue

3 Tobacco control policies

and public health

measures

0 – 9 8  National objectives on tobacco control and a national agency for tobacco control exist.^8

 Spain is party to World Health Organization (WHO) Framework Convention on Tobacco

Control (FCTC).

 Advertising is banned on national TV and radio.

 Law mandates that health warnings appear on tobacco packages.

 National smoke-free legislation exists for indoor offices, restaurants/cafes/ pubs/bars and

public transportation.

 There was no national mass media campaign during the survey period (up to 2016).

4 E-cigarettes regulation

and public health

measures

0 – 4 2  Safety and quality standards for e-cigarette regulation are in place.

 The sale of e-cigarettes is not expressly prohibited for people under 18 years of age. The

packaging is mandated to contain a leaflet that states “the product is not recommended for

use by young people and non-smokers, a recommendation to keep the product out of the

reach of children.”

 Advertising and promotion is prohibited.

 There is no information on whether or where the use of e-cigarettes is banned.

5 National policies

and programmes for

environmental exposure

control

0 – 2 1  Spain has a National Air Quality and Atmospheric Protection Plan, 2013-2016.

 Spain does not have a national radon control plan.

6 Evidence-based

approach to lung cancer

screening

0 – 1 0  No data found to show that Spain has conducted a lung cancer screening study or trial.

7 Patient organisations

involvement in policy

development

0 – 3 1  Lung cancer patient organisation exists in Spain.

 No clear evidence to suggest that patients were represented in clinical guideline

development.

 There is no process to involve civil society in Health Technology Assessments (HTAs).

Lung cancer is a race against time

8 Suspected lung cancer

patient diagnosis within

a specific time frame

0 – 2 0  No mention of patients to be fast-tracked in lung cancer clinical guidelines.

 No mention of a specific timeframe for diagnostic referral in suspected lung cancer

patients.

 There is some anecdotal evidence to suggest that pathways may exist and that patients

may be fast-tracked in regional and local hospital settings.

9 Guidelines / pathways

for rapid referral to

quality care

0 – 2 0  No mention of rapid referral for lung cancer patients to secondary / tertiary care.

 The guidelines do not mention multidisciplinary teams. Multidisciplinary cancer care

models are discussed in the National Cancer Strategy 2009.